We are live on
!
Find out more
Sanofi
SNY
SNY
474 hedge funds and large institutions have $11.3B invested in Sanofi in 2017 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 127 increasing their positions, 187 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
710% more call options, than puts
Call options by funds: $88.5M | Put options by funds: $10.9M
83% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 29
4% more funds holding
Funds holding: 454 → 474 (+20)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
0% less capital invested
Capital invested by funds: $11.4B → $11.3B (-$33.8M)
0.67% less ownership
Funds ownership: 19.33% → 18.66% (-0.67%)
32% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 187
Holders
474
Holders Change
+20
Holders Change %
+4.41%
% of All Funds
11.82%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.25%
New
53
Increased
127
Reduced
187
Closed
29
Calls
$88.5M
Puts
$10.9M
Net Calls
+$77.5M
Net Calls Change
+$82.1M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$70.1M |
| 2 |
SCA
Southpoint Capital Advisors
New York
|
+$57.3M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
+$48.9M |
| 4 |
BlackRock
New York
|
+$34.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$28.3M |
